Clinical Trial Update: Early Treatment of Recurrent HCV- Infection Post Liver Transplantation in the Era of DAAs [Phase 4]

View source ↗

Summary

Phase 4 study evaluating early treatment of recurrent hepatitis C infection after liver transplantation using direct-acting antivirals; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Direct-acting antivirals (direct-acting antivirals)

Snippet

Sponsor: Ain Shams University | Conditions: Liver Transplantation | Phase 4 | Status: COMPLETED